Employee stock option accounting journal entries
One of the best ways to attract talent is to offer them stock options as part of their compensation package. The process for awarding stock compensation is standard enough; you do the legwork required to grant stock options at the correct strike price, you offer those options to your employees, the options vest, and the employees have the opportunity to exercise them. So what happens if that process is derailed by expired stock options? How would you account for and track expired option grants?
Expensing Stock Options: A Fair-Value Approach
Expensing options is good in theory and practice. This new treatment ensures that estimates of stock option value reflect both the nature of the incentive contract and the subsequent market reality. Now that companies such as General Electric and Citigroup have accepted the premise that employee stock options are an expense, the debate is shifting from whether to report options on income statements to how to report them. A procedure they call fair-value expensing adjusts and eventually reconciles cost estimates made at grant date with subsequent changes in the value of the options, and it does so in a way that eliminates forecasting and measurement errors over time.
The method captures the chief characteristic of stock option compensation—that employees receive part of their compensation in the form of a contingent claim on the value they are helping to produce. The mechanism involves creating entries on both the asset and equity sides of the balance sheet.
The prepaid-compensation account is then expensed through the income statement, and the stock option account is adjusted on the balance sheet to reflect changes in the estimated fair value of the granted options. At the end of the vesting period, the company uses the fair value of the vested option to make a final adjustment on the income statement to reconcile any difference between that fair value and the total of the amounts already reported.
Now that companies such as General Electric, Microsoft, and Citigroup have accepted the premise that employee stock options are an expense, the debate on accounting for them is shifting from whether to report options on income statements to how to report them.
The opponents of expensing, however, continue to fight a rearguard action, arguing that grant-date estimates of the cost of employee stock options, based on theoretical formulas, introduce too much measurement error. They want the reported cost deferred until it can be precisely determined—namely when the stock options are exercised or forfeited or when they expire.
But deferring recognition of stock option expense flies in the face of both accounting principles and economic reality.
Expenses should be matched with the revenues associated with them. The cost of an option grant should be expensed over the time, typically the vesting period, when the motivated and retained employee is presumed to be earning the grant by generating additional revenues for the company.
Some degree of measurement error is no reason to defer recognition; accounting statements are filled with estimates about future events—about warranty expenses, loan loss reserves, future pension and postemployment benefits, and contingent liabilities for environmental damage and product defects.
The final defense of the antiexpensing lobby is its claim that other financial-statement estimates based on future events are eventually reconciled to the settlement value of the items in question. For instance, estimated costs for pension and postretirement benefits and for environmental and product-safety liabilities are ultimately paid in cash.
At that time, the income statement is adjusted to recognize any difference between actual and estimated cost. As the opponents of expensing point out, no such correcting mechanism currently exists to adjust grant-date estimates of stock option costs.
A procedure that we call fair-value expensing for stock options eliminates forecasting and measurement errors over time. A procedure that we call fair-value expensing adjusts and eventually reconciles cost estimates made at grant date to subsequent actual experience in a way that eliminates forecasting and measurement errors over time. Our proposed method involves creating entries on both the asset and equity sides of the balance sheet for each option grant.
This accounting mirrors what companies would do if they were to issue conventional options and sell them into the market in that case, the corresponding asset would be the cash proceeds instead of prepaid compensation. The prepaid-compensation account is then expensed through the income statement following a regular straight-line amortization schedule over the vesting period—the time during which the employees are earning their equity-based compensation and, presumably, producing benefits for the corporation.
At the same time that the prepaid-compensation account is expensed, the stock option account is adjusted on the balance sheet to reflect changes in the estimated fair value of the granted options. The company obtains the periodic revaluation of its options grant just as it did the grant-date estimate, either from a stock options valuation model or an investment-bank quote.
The amortization of prepaid compensation is added to the change in the value of the option grant to provide the total reported expense of the options grant for the year.
At the end of the vesting period, the company uses the fair value of the vested stock option—which now equals the realized compensation cost of the grant—to make a final adjustment on the income statement to reconcile any difference between that fair value and the total of the amounts already reported in the manner described. The options can now be quite accurately valued, as there are no longer any restrictions on them.
Market quotes would be based on widely accepted valuation models. In this case, the cost to the company will be less than if the employee had retained the options because the employee has forgone the valuable opportunity to see the evolution of stock prices before putting money at risk. The approach we have described is not the only way to implement fair-value expensing.
Companies may choose to adjust the prepaid-compensation account to fair value instead of the paid-in capital option account. In this case, the quarterly or annual changes in option value would be amortized over the remaining life of the options. This would reduce the periodic fluctuations in option expense but involve a slightly more complex set of calculations.
The great advantage of fair-value expensing is that it captures the chief characteristic of stock option compensation—namely that employees are receiving part of their compensation in the form of a contingent claim on the value they are helping to produce. Fair-value expensing captures the chief characteristic of stock option compensation—that employees receive part of their pay in the form of a contingent claim on value they are helping to produce.
If the market is actually trading options with exactly the same exercise price and maturity as the vested stock options, Kalepu can use the quoted price for those options instead of the model on which that quoted price would be based. What happens if an employee holding the grant decides to leave the company before vesting, thereby forfeiting the unvested options? When options vest in the money, however, some employees may choose to exercise immediately rather than retain the full value by waiting to exercise until the options are about to expire.
In this case, the firm can use the market price of its shares at the vesting and exercise dates to close off the reporting for the grant. The objective of financial accounting is not to reduce measurement error to zero. In a similar way, if the FASB and International Accounting Standards Board were to recommend fair-value expensing for employee stock options, companies could make their best estimates about total compensation cost over the vesting life of the options, followed by periodic adjustments that would bring reported compensation expense closer to the actual economic cost incurred by the company.
Robert S. He is a coauthor, with Michael E. Krishna G. Palepu kpalepu hbs. Kaplan and Krishna G. December Issue Explore the Archive. Executive Summary Reprint: RJ Now that companies such as General Electric and Citigroup have accepted the premise that employee stock options are an expense, the debate is shifting from whether to report options on income statements to how to report them. Fair-Value Expensing. A version of this article appeared in the December issue of Harvard Business Review.
Related Topics:. Partner Center.
Accountants need to book a separate journal entry when the employees exercise stock options. First, the accountant must calculate the cash that the business. proposed accounting for stock option awards to employees. 12/ The following journal entries illustrate the compensation cost to be recorded. The par.
Companies pay its employees using cash and stocks. All cash payments made to employees are shown as expenses in the income statement. In this post, I will try to unravel the accounting for stock compensation. I will explain them by using a fictitious company called TestCo. Given below is the journal entry for this transaction.
Stock option compensation is a form of equity based compensation in which a business rewards key personnel by granting them the rights to purchase shares in the business in return for their services.
Since stock option plans are a form of compensation, generally accepted accounting principles, or GAAP, requires businesses to record stock options as a compensation expense for accounting purposes. Rather than recording the expense as the current stock price, the business must calculate the fair market value of the stock option. The accountant will then book accounting entries to record compensation expense, the exercise of stock options and the expiration of stock options.
Journal Entries of ESOP
Expensing options is good in theory and practice. This new treatment ensures that estimates of stock option value reflect both the nature of the incentive contract and the subsequent market reality. Now that companies such as General Electric and Citigroup have accepted the premise that employee stock options are an expense, the debate is shifting from whether to report options on income statements to how to report them. A procedure they call fair-value expensing adjusts and eventually reconciles cost estimates made at grant date with subsequent changes in the value of the options, and it does so in a way that eliminates forecasting and measurement errors over time. The method captures the chief characteristic of stock option compensation—that employees receive part of their compensation in the form of a contingent claim on the value they are helping to produce. The mechanism involves creating entries on both the asset and equity sides of the balance sheet.
How to Do Accounting Entries for Stock Options
Stock option expensing is a method of accounting for the value of share options, distributed as incentives to employees, within the profit and loss reporting of a listed business. On the income statement, balance sheet, and cash flow statement say that the loss from the exercise is accounted for by noting the difference between the market price if one exists of the shares and the cash received, the exercise price, for issuing those shares through the option. Opponents of considering options an expense say that the real loss — due to the difference between the exercise price and the market price of the shares — is already stated on the cash flow statement. They would also point out that a separate loss in earnings per share due to the existence of more shares outstanding is also recorded on the balance sheet by noting the dilution of shares outstanding. Simply, accounting for this on the income statement is believed to be redundant to them. Note: Currently, the future appreciation of all shares issued are not accounted for on the income statement but can be noted upon examination of the balance sheet and cash flow statement. The two methods to calculate the expense associated with stock options are the "intrinsic value" method and the "fair-value" method. Only the fair-value method is currently U. The intrinsic value method, associated with Accounting Principles Board Opinion 25 , calculates the intrinsic value as the difference between the market value of the stock and the exercise price of the option at the date the option is issued the "grant date". Since companies generally issue stock options with exercise prices which are equal to the market price, the expense under this method is generally zero.
All other stock option plans are assumed to be a form of compensation, which requires recognition of an expense under U.
Journal entries provide foundational information for all financial reporting and are used by auditors to analyze the appropriateness of transactions recorded in ledger and how such financial transactions impact a business. Companies are required to record transactions to ledger in accordance to their Financial Reporting Method. Below is a list of Journal Entries Carta provide to assist with recording your stock-based compensation transactions as ease:. As early exercised options are still subject to vesting, the shared though exercised is not considered issued.
